Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
PURPOSE: Phase II trial to study the effectiveness of combining capecitabine and irinotecan
in treating patients who have locally advanced, recurrent, or metastatic colorectal cancer.